American Beacon Stephens Small Cap Growth Fund Investor Class (STSGX)

Fund Assets	525.41M
Expense Ratio	1.287%
Min. Investment	$2,500
Turnover	35.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 22, 2025

Previous Close	13.33
YTD Return	12.45%
1-Year Return	9.52%
5-Year Return	21.98%
52-Week Low	11.35
52-Week High	14.56
Beta (5Y)	1.23
Holdings	99
Inception Date	Dec 1, 2005

About STSGX

The American Beacon Stephens Small Cap Growth Fund Investor Class is a mutual fund focused on achieving long-term capital growth by investing primarily in small-capitalization growth companies. Managed by Stephens Investment Management Group, the fund leverages fundamental analysis to identify and select U.S. companies with strong growth prospects, typically within the market capitalization range of the Russell 2000 Index. The fund maintains a diversified portfolio across multiple sectors, with notable allocations in technology, consumer defensive, industrials, energy, healthcare, and financial services. Its investment strategy is based on the belief that the small-cap market segment is less efficient and often contains some of the fastest-growing companies, though it may involve heightened volatility and liquidity risks compared to larger-cap investments. The fund benchmarks its performance against the Russell 2000 Growth Index and aims to harness the growth potential of well-researched small-cap stocks, making it a significant player in the small-cap growth category within the mutual fund landscape.

• Fund Family: American Beacon
• Category: Small Growth
• Performance Rating: Above Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: STSGX
• Share Class: Investor Class
• Index: Russell 2000 Growth TR

Performance

STSGX had a total return of 9.52% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.98%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FECGX	Fidelity	Fidelity Small Cap Growth Index Fund	0.05%
FCIGX	Fidelity	Fidelity Advisor Small Cap Growth I	0.88%
FCPGX	Fidelity	Fidelity Small Cap Growth Fund	0.87%
FCTGX	Fidelity	Fidelity Advisor Small Cap Growth M	1.44%
FCCGX	Fidelity	Fidelity Advisor Small Cap Growth C	1.86%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
STSRX	R6 Class	0.96%
STSIX	R5 Class	0.99%
SPWYX	Y Class	1.05%
SPWAX	A Class	1.28%

Top 10 Holdings

18.56% of assets

Name	Symbol	Weight
Halozyme Therapeutics, Inc.	HALO	2.03%
Ligand Pharmaceuticals Incorporated	LGND	1.99%
Repligen Corporation	RGEN	1.93%
FirstCash Holdings, Inc.	FCFS	1.91%
Xometry, Inc.	XMTR	1.88%
Travere Therapeutics, Inc.	TVTX	1.84%
EZCORP, Inc.	EZPW	1.77%
Manhattan Associates, Inc.	MANH	1.76%
Twist Bioscience Corporation	TWST	1.73%
U.S. Government Money Market S	n/a	1.71%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$1.3889	Dec 23, 2025
Dec 20, 2024	$0.9945	Dec 23, 2024
Dec 21, 2023	$0.1708	Dec 22, 2023
Dec 22, 2022	$1.4442	Dec 23, 2022
Dec 22, 2020	$1.9253	Dec 23, 2020
Dec 20, 2019	$1.6108	Dec 23, 2019

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error